Further analysis proved that DACH1 inhibited the transcription of cyclin D1 and cyclin A by directly binding to its corresponding promoter region, thereby further repressing the proliferation of cells and tumor growth in various cancer types, such as BC and renal cancer [34, 70, 103–105]. Here, CCNA2 is linked to breast cancer.